Weekly Futures Recap With Mike Seery

We've asked Michael Seery of SEERYFUTURES.COM to give our INO readers a weekly recap of the Futures market. He has been Senior Analyst for close to 20 years and has extensive knowledge of all of the commodity and option markets.

Michael frequently appears on multiple business networks including Bloomberg news, Fox Business, CNBC Worldwide, CNN Business, and Bloomberg TV. He is also a guest on First Business, which is a national and internationally syndicated business show.

Crude Oil Futures

Crude oil futures in the November contract settled last Friday in New York at 50.44 a barrel while currently trading at 50.50 primarily unchanged for the trading week which is a rare occurrence as this is a very volatile commodity. I will be recommending a bullish position if prices close above 50.88 while then placing the stop loss under the 10-day low standing at 48.28 risking around $1,300 per mini contract plus slippage and commission. Oil prices are right at a 15-week high trading above their 20 and 100-day moving average telling you that the short-term trend is higher with heating oil hitting another contract high in today's trade while unleaded gasoline continues to remain firm. I am bullish the entire sector across the board. The chart structure in crude oil is excellent due to low volatility, and we could be involved in a bullish position at Friday's close so keep a close eye on this market as I think the commodities, in general, are moving higher as the bearish trends have finally come to an end in my opinion.
TREND: HIGHER
CHART STRUCTURE: EXCELLENT

Continue reading "Weekly Futures Recap With Mike Seery"

Hemp For Pets Company Up 122% In 2017

Analysis originally distributed on September 14, 2017 By: Michael Vodicka of Cannabis Stock Trades

Pets are big business in the US and around across the globe.

In 2016 U.S. consumers spent over $67 billion on pet-related products, up 11% from the year before.

While food accounts for the highest percent of spending, pet medications were close behind at $8 billion. Spending on pet medications is expected to grow another 10% in 2017 to $9 billion.

These huge sales numbers have gotten the attention of the cannabis industry. Capturing even a small percent of the pet medication market could mean hundreds of millions in profit.

That's why I am excited to share an early industry leader that most investors have never heard of.

- Sales are up more than 1,000% in the last 12 months.
- Shares have risen 122% since January.

With the cannabis for pets industry still in its early stages - I see plenty of room for growth for this undercover cannabis company. True Leaf Medicine International Ltd. (TRLFF) is a Canadian cannabis company founded in 2013 and headquartered in British Columbia.

Trueleaf

Shares are listed on the Canadian Securities Exchange under the ticker symbol MJ. I see average daily trading volume around 100,000 shares here, so this stock has plenty of liquidity for most investors. Continue reading "Hemp For Pets Company Up 122% In 2017"

Weekly Futures Recap With Mike Seery

We've asked Michael Seery of SEERYFUTURES.COM to give our INO readers a weekly recap of the Futures market. He has been Senior Analyst for close to 15 years and has extensive knowledge of all of the commodity and option markets.

Michael frequently appears on multiple business networks including Bloomberg news, Fox Business, CNBC Worldwide, CNN Business, and Bloomberg TV. He is also a guest on First Business, which is a national and internationally syndicated business show.

Gold Futures

Gold futures in the December contract settled last Friday in New York at 1,351 an ounce while currently trading at 1,328 down about $23 for the trading week. For the 1st time in over a month prices traded lower and may have topped out in the short-term at 1,362 as profit-taking has ensued pushing prices lower this week. If you are long a futures contract, the chart structure has turned outstanding, and I would place my stop loss as an exit strategy below the 10-day low standing at 1,319 which is just about $10 away. Prices are still trading above their 20 and 100-day moving average as the trend remains higher in my opinion. The U.S. dollar traded sideways this week lending little support for gold prices as the story is all about North Korea and if or if they don't send a missile over the weekend sending prices higher or lower. There is still a high demand for physical gold at this time so continue to play this to the upside. Volatility in gold is relatively high as the higher price goes in a commodity, the higher the volatility as well that is why you can see $10/$15 trading ranges on a daily basis. Make sure you place the proper amount of contracts as I think the volatility will even increase throughout 2017.
TREND: HIGHER
CHART STRUCTURE: EXCELLENT

Continue reading "Weekly Futures Recap With Mike Seery"

Australian Cannabis Biotech Up 271%

Analysis originally distributed on August 30, 2017 By: Michael Vodicka of Cannabis Stock Trades

Opioid abuse has quickly grown into a major global epidemic.

While opioids can be great for pain relief, the down side is that they are highly addictive. Recent data shows that opioid abuse and addiction is killing tens of thousands of people every year in just the United States.

Overdose deaths caused by prescription opioids have quadrupled since 1999. From 1999 to 2015, more than 183,000 people have died in the U.S. from overdoses related to prescription opioids.

This is an alarming trend that has both patients and health care professionals asking - are we capable of providing a better alternative?

According to a young biotech located Australia the answer is yes - and the solution comes in the form of cannabis.

If this young cannabis biotech is correct, not only will patients benefit, early shareholders will be rewarded with huge gains.

Let's take a look. Continue reading "Australian Cannabis Biotech Up 271%"

Australian Cannabis Biotech Developing Cancer and Epilepsy Drugs

Analysis originally distributed on August 23, 2016 By: Michael Vodicka of Cannabis Stock Trades

MGC Pharmaceuticals (TSX:MXC, OTC:MGCLF) is a young cannabis biotech headquartered in Western Australia that specializes in pharmaceutical product research and development.

MGC

Australian cannabis stocks have been red hot for the last few months.

  • I added Australian-based Cann Group (ASX:CAN) to the members portfolio on July 31 and we're already up 70% in less than three weeks.
  • I added fellow Australian cannabis stock AusCann (OTC:ACNNF) to the member portfolio on June 6 and we're up 55%.

If you want to learn more about our member portfolio click here.

Although the company is incorporated and headquartered in Australia it also has operations in both Israel and Europe.

For example, MGC received two licenses from the Slovenian government to grow, process and trade Cannabis Sativa L (Hemp) and its products, including Cannabidoil (CBD) resin, in Europe.

The company's founders were leaders in Israel's growing medical cannabis industry. Continue reading "Australian Cannabis Biotech Developing Cancer and Epilepsy Drugs"